Skip Nav Destination
1-20 of 139
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Exceptionally Potent Cytotherapy Using T Cells Armed with Novel Tetravalent Recombinant Bispecific Antibodies Specific for GD2 and HER2
Blood (2018) 132 (Supplement 1): 4536.
Selma Bekri, PhD, Reunet Rodney-Sandy, BS, Diana Gruenstein, BS, Bjarne Bogen, MD PhD, Daniel Levey, PhD, Hearn Jay Cho, MD
Blood (2018) 132 (Supplement 1): 1947.
Nadia Carenina Nunes Cavalcante Parr, MD, Muhammad Junaid Tariq, MD, Muhammad Usman, MD, Muhammad Asad Fraz, MD, Ali Younas Khan, MD, Sharoon Samuel, MBBS, Awais Ijaz, MD, Malik Qistas Ahmad, MD MBBS, Muhammad Jahanzeb Khalil, MD, Muhammad Yasir, MD, Saher Nasir Amin, MD, Ahmad Safdar, Abdul Rafae, MD, Faiz Anwer, MD
Blood (2018) 132 (Supplement 1): 5635.
Daratumumab (DARA) in Combination with Carfilzomib, Lenalidomide, and Dexamethasone (KRd) in Patients with Newly Diagnosed Multiple Myeloma (MMY1001): Updated Results from an Open-Label, Phase 1b Study
Ajai Chari, Saad Z Usmani, MD, Amrita Krishnan, MD, Sagar Lonial, MD, Raymond Comenzo, Kaida Wu, Jianping Wang, Parul Doshi, Brendan M Weiss, MD, Jordan Schecter, Andrzej J. Jakubowiak, MD
Blood (2017) 130 (Supplement 1): 3110.
Novel CD19/CD22 Bicistronic Chimeric Antigen Receptors Outperform Single or Bivalent Cars in Eradicating CD19 + CD22 + , CD19 - , and CD22 - Pre-B Leukemia
Haiying Qin, MS, Sang M Nguyen, BS, Sneha Ramakrishna, MD, Samiksha Tarun, MSc, Lila Yang, BS, Nicholas Peter Verdini, BS, Waleed Haso, MS, Terry J. Fry, MD
Blood (2017) 130 (Suppl_1): 810.
Randomized Phase II Trial of Combination Idiotype Vaccine and Adoptive Cell Transfer of Costimulated Autologous T Cells in Patients with Multiple Myeloma Post-Autotransplantation
Muzaffar H. Qazilbash, MD, Edward A Stadtmauer, MD, Veera Baladandayuthapani, PhD, Heather Lin, Beryl Tross, RN, Medhavi Honhar, Soung-chul Cha, PhD, Kunhwa Kim, MDMPH, Michael Popescu, Nina Shah, MD, Qaiser Bashir, MD MBBS, Krina K. Patel, MDMSc, Vincent Young Lee, Elizabeth J Shpall, MD, Donna M. Weber, MD, Sheeba K. Thomas, MD, Robert Z. Orlowski, MD PhD, Naseem Kerr, MPH, Alfred L. Garfall, MD, Adam D. Cohen, MD, Dan T. Vogl, MD, Karen Dengel, BSN, RN, Carl H June, MD, Richard E Champlin, MD, Larry W Kwak, MDPhD
Blood (2017) 130 (Supplement 1): 3193.
Neoantigen Synthetic Peptide Vaccine for Multiple Myeloma Elicits T Cell Immunity in a Pre-Clinical Model
Selma Bekri, PhD, Mohamed Uduman, PhD, Diana Gruenstein, BS, Anna Huo-Chang Mei, MS, Kaity Tung, BS, Reunet Rodney-Sandy, BS, Bjarne Bogen, MD PhD, Jennifer Buell, PhD, Robert Stein, MD PhD, Kaitlin Doherty, Mark Findeis, PhD, Benjamin Morin, PhD, Bishnu Joshi, PhD, Antoine Tanne, PhD, John Castle, PhD, Daniel Levey, PhD, Hearn Jay Cho, MD PhD
Blood (2017) 130 (Supplement 1): 1868.
A Cellular Antidote to Specifically Deplete Anti-CD19 Chimeric Antigen Receptor (CAR19) Positive Cells
Marco Ruella, MD, David M. Barrett, Olga Shestova, PhD, Jessica Perazzelli, PhD, Avery D. Posey, PhD, Miroslaw Kozlowski, PhD, Simon F Lacey, PhD BS, J. Joseph Melenhorst, PhD, Carl H June, MD, Saar I. Gill, MD PhD
Blood (2017) 130 (Supplement 1): 4463.
Endogenous Immunoglobulin-Derived Neoepitopes Are Processed and Form a Sizeable Fraction of the HLA Class I Ligandome of Human Lymphoma Cells
Cornelis A.M. van Bergen, PhD, Dirk M. van der Steen, Michel G.D. Kester, Marvyn T. Koning, BSc, Peter A. van Veelen, PhD, Marieke Griffioen, PhD, J.H. Frederik Falkenburg, MD PhD, Mirjam H.M. Heemskerk, PhD, Hendrik Veelken, MD PhD, Marcelo A Navarrete, MD PhD
Blood (2016) 128 (22): 914.
Immune Checkpoint Blockade Combinations As Promising Strategy for Cancer Immunotherapy in Multiple Myeloma Patients
Barbara Castella, PhD, Myriam Foglietta, MD, Patrizia Sciancalepore, MD, Ezio Tripoli, PharmD, Mario Boccadoro, MD, Massimo Massaia, MD
Blood (2016) 128 (22): 2059.
Randomized Phase II Trial of Combination Idiotype Vaccine and Anti-CD3/Anti-CD28 Costimulated Autologous T Cells in Patients with Multiple Myeloma Post-Autotransplantation
Muzaffar H. Qazilbash, MD, Edward A Stadtmauer, MD, Veera Baladandayuthapani, PhD, Heather Lin, M.S., Beryl M. Tross, Medhavi Honhar, MBBS, Soung-Chul Cha, PhD, Kunhwa Kim, MD, Sheetal S Rao, PhD, Michael Popescu, MD, Nina Shah, MD, Qaiser Bashir, MD, Krina Patel, MD, Elizabeth J. Shpall, MD, Donna M. Weber, MD, Sheeba K. Thomas, MD, Jatin J. Shah, MD, Robert Z. Orlowski, PhD, MD, Naseem DS Kerr, MPH, Alfred L. Garfall, MD, Adam D. Cohen, MD, Karen Dengel, BSN, RN, Carl H June, MD, Richard E. Champlin, MD, Larry Kwak, MD PhD
Blood (2016) 128 (22): 4548.
Quantitative Baseline Circulating Tumor DNA Levels Correlate with GM-CSF Response to Idiotype Vaccine in Untreated Mantle Cell Lymphoma
Mark Roschewski, MD, Kieron Dunleavy, MD, Sattva S. Neelapu, MD, Stefania Pittaluga, MD PhD, Christopher Joseph Melani, MD, Elaine S. Jaffe, MD, Margaret Shovlin, RN, Beryl Crossley, BS, Katie Kong, BS, Allison Jacob, MD, Larry Kwak, Wyndham H. Wilson, MD PhD
Blood (2016) 128 (22): 2943.
Development of a Novel Virus-like Particle (VLP) Vaccine for Personalized B-Cell Lymphoma and Chronic Lymphocytic Leukemia Therapy
Blood (2015) 126 (23): 2748.
Kim De Veirman, Jo A. Van Ginderachter, Ivan Van Riet, Nathan De Beule, Susanne Lub, Eline Menu, PhD, Elke De Bruyne, PhD, Karin Vanderkerken, PhD, Els Van Valckenborgh, PhD
Blood (2014) 124 (21): 2009.
Functional Analysis of Phage Display Selected Single-Chain Variable Antibody Fragments (scFvs) Specific for Anti-FVIII Antibodies
Kerstin Brettschneider, Anja Naumann, Sonja Neimanis, PhD, Joerg Kahle, PhD, Christine Heller, MD, Thomas Klingebiel, MD, Dirk Schwabe, MD, Christoph Koenigs, PhD MD
Blood (2014) 124 (21): 1499.
131 I-Tositumomab Consolidation Radioimmunotherapy (RIT) In Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Or Small Lymphocytic Lymphoma (SLL) In First Remission
Mazyar Shadman, MD, MPH, Ajay K. Gopal, MD, Pamela S. Becker, MD, PhD, David G. Maloney, MD, PhD, Barbara Pender, Andrei R. Shustov, MD, Raya Mawad, MD, Britt Kammerer, Oliver W. Press, MD, PhD, John M. Pagel, MD, PhD
Blood (2013) 122 (21): 1644.
Marcelo Navarrete, MD, Florian Scherer, MD, Marlon van der Burgt, Szymon Kielbasa, PhD, Hendrik Veelken, MD PhD
Blood (2013) 122 (21): 4258.
High-Throughput Screening of a Large Combinatorial Library of Small Proteins Against Human Spleen-Derived Monoclonal Anti-ADAMTS13 Antibodies Yields Specific Anti-Idiotypic Molecules – Potential Tools for New Treatment Strategy in Acquired TTP
Monica Schaller, PhD, Sabine Hiltbrunner, Irmela Sulzer, Monique Vogel, PhD, Karim Kentouche, MD, Bernhard Laemmle, MD, Johanna A. Kremer Hovinga
Blood (2012) 120 (21): 487.
Anja Naumann, Jörg Kahle, Nadia Reiss, Dirk Schwabe, Christine Heller, Thomas Klingebiel, MD, Christoph Königs, MD, PhD
Blood (2012) 120 (21): 3361.
Targeting B-Cell Lymphoma with Idiotype-Specific Peptibodies: Toward a Personalized and Tumor-Specific Therapy
James A Torchia, Patrick P Ng, PhD, Homer Chen, Holbrook E Kohrt, MD, PhD, Aurelien Marabelle, MD, MSc, Ash A. Alizadeh, MD, PhD, Ronald Levy, MD
Blood (2012) 120 (21): 3713.